CD40LG and allergic disease: The aim of this study was to evaluate a COVID-19 vaccine allergy using in vitro T-cell exposure to the tested drug with the flow cytometry measurement of CD69, CD40L, TNFa, IFNG, IL-2, IL-4, IL-6, IL-10, intracellular granulysin, and IFNgamma.